Literature DB >> 27686048

Huntington disease: Selective deactivation of Huntington disease mutant allele by CRISPR-Cas9 gene editing.

Hemi Malkki.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27686048     DOI： 10.1038/nrneurol.2016.151

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.

Authors:  Jun Wan Shin; Kyung-Hee Kim; Michael J Chao; Ranjit S Atwal; Tammy Gillis; Marcy E MacDonald; James F Gusella; Jong-Min Lee
Journal:  Hum Mol Genet       Date:  2016-10-15       Impact factor: 6.150
  1 in total
  2 in total

1.  Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa.

Authors:  Pingjuan Li; Benjamin P Kleinstiver; Mihoko Y Leon; Michelle S Prew; Daniel Navarro-Gomez; Scott H Greenwald; Eric A Pierce; J Keith Joung; Qin Liu
Journal:  CRISPR J       Date:  2018-02

Review 2.  Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.

Authors:  Sudhanshu P Raikwar; Nidhi S Kikkeri; Ragha Sakuru; Daniyal Saeed; Haris Zahoor; Keerthivaas Premkumar; Shireen Mentor; Ramasamy Thangavel; Iuliia Dubova; Mohammad Ejaz Ahmed; Govindhasamy P Selvakumar; Duraisamy Kempuraj; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-23       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.